- Inhibition of mTORC1 by SU6656, the Selective Src Kinase Inhibitor, Is Not Accompanied by Activation of Akt/PKB Signalling in Melanoma Cells2013 | 1. lékařská fakulta, 3. lékařská fakulta
- Cerebellar demyelination and neurodegeneration associated with mTORC1 hyperactivity may contribute to the developmental onset of autism-like neurobehavioral phenotype in a rat model2022 | 3. lékařská fakulta, Ústřední knihovna
- Účast c-Src aktivity v mTOR-závislé onkogenicitě melanomových buněkPublikace bez příslušnosti k fakultě
- Regulace mTORC signalizace Src kinázovou aktivitou je v RSV-transformovaných buňkách nezávislá na Akt12008 | 1. lékařská fakulta
- Developmental effects of constitutive mTORC1 hyperactivity and environmental enrichment on structural synaptic plasticity and behaviour in a rat model of autism spectrum disorder2023 | 1. lékařská fakulta, Přírodovědecká fakulta, Ústřední knihovna
- Aktivita c-Src jako nový molekulární cíl pro inhibici mTOR signalizace u lidských nemocíPublikace bez příslušnosti k fakultě
- The landscape of epilepsy-related GATOR1 variants2019 | 2. lékařská fakulta
- A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development2023 | Přírodovědecká fakulta
- Integrated actions of mTOR complexes 1 and 2 for growth and development of Dictyostelium2019 | Přírodovědecká fakulta
- MicroRNA-34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis2021 | 2. lékařská fakulta
- The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas2020 | 2. lékařská fakulta
- Involvement of mTOR Pathways in Recovery from Spinal Cord Injury by Modulation of Autophagy and Immune Response2021 | 2. lékařská fakulta
- Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)2022 | Publikace bez příslušnosti k fakultě
- Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes2021 | 3. lékařská fakulta
- The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury2023 | 2. lékařská fakulta
- Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics2022 | Lékařská fakulta v Hradci Králové
- TSC/mTOR pathway mutation associated eosinophilic/oncocytic renal neoplasmsm: a heterogeneous group of tumors with distinct morhpology, immunohistochemical profile, and similar genetic background2022 | Lékařská fakulta v Plzni
- mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis2022 | 1. lékařská fakulta
- Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8(+) T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness2019 | 2. lékařská fakulta
- Acute Conditioning of Antigen-Expanded CD8(+) T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge2020 | 2. lékařská fakulta
- Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment2017 | 2. lékařská fakulta
- Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex2016 | 2. lékařská fakulta
